AGM/EGM1 Sept 2026, 04:55 pm
Venmax Drugs Submits FY26 Annual Report & AGM Notice
AI Summary
Venmax Drugs and Pharmaceuticals Ltd has submitted its Annual Report for the Financial Year 2025-26, as per SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. The report includes the notice for the 37th Annual General Meeting (AGM), scheduled for September 26, 2026, to be held via Video Conferencing. The filing details the company's corporate information, board of directors, registered office, statutory auditors (PPKG & CO), RTA (CIL Securities Limited), and bankers (ICICI Bank).
Key Highlights
- Annual Report for FY25-26 submitted.
- 37th AGM scheduled for September 26, 2026.
- AGM to be conducted via Video Conferencing.
- Corporate information and director details provided.
- Statutory auditors and RTA listed.
Price Impact
More from VENMAX